[HTML][HTML] Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject�…
Background People who inject drugs are exposed to various and changing risk
environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed�…
environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed�…
[HTML][HTML] Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review
Background Stimulant drugs are second only to cannabis as the most widely used class of
illicit drug globally, accounting for 68 million past-year consumers. Dependence on�…
illicit drug globally, accounting for 68 million past-year consumers. Dependence on�…
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address�…
use of, and dependence on, these drugs, and a wide range of interventions used to address�…
COVID-19 and the health of people who use drugs: What is and what could be?
Abstract SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know
it, and continues to do so. How COVID-19 affects people who use drugs, the environments in�…
it, and continues to do so. How COVID-19 affects people who use drugs, the environments in�…
[HTML][HTML] Non-pharmacological interventions for methamphetamine use disorder: a systematic review
PV AshaRani, A Hombali, E Seow, WJ Ong…�- Drug and Alcohol�…, 2020 - Elsevier
Background Methamphetamine (METH) use is on the rise globally, with the number of
treatment seekers increasing exponentially across the globe. Evidence-based therapies are�…
treatment seekers increasing exponentially across the globe. Evidence-based therapies are�…
Association of pharmacological treatments and hospitalization and death in individuals with amphetamine use disorders in a Swedish nationwide cohort of 13 965�…
M Hartikainen, H Taipale, A Tanskanen…�- JAMA�…, 2023 - jamanetwork.com
Importance There are no medications approved by authorities for the treatment of
amphetamine or methamphetamine dependence, and studies investigating the�…
amphetamine or methamphetamine dependence, and studies investigating the�…
[HTML][HTML] Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs
The market for illicit drugs and new psychoactive substances (NPS) has grown significantly
and people attending festivals have been identified as being at high risk (high extent and�…
and people attending festivals have been identified as being at high risk (high extent and�…
Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials
LS Acheson, BH Williams, M Farrell…�- Drug and Alcohol�…, 2023 - Wiley Online Library
Issues Cessation of methamphetamine use may result in a characteristic withdrawal
syndrome, no medication has been approved for this indication. This systematic review aims�…
syndrome, no medication has been approved for this indication. This systematic review aims�…
[HTML][HTML] Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
Background There is high co-occurrence of substance use disorders (SUD) and mental
health disorders. We aimed to assess impact of substance use patterns and�…
health disorders. We aimed to assess impact of substance use patterns and�…
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: A randomized placebo‐controlled trial
V Mongeau‐P�russe, S Brissette, J Bruneau…�- …, 2021 - Wiley Online Library
ABSTRACT Background and Aims Cocaine use disorder (CUD) is a significant public health
concern for which no efficacious pharmacological interventions are available. Cannabidiol�…
concern for which no efficacious pharmacological interventions are available. Cannabidiol�…